Desarrollo de nuevas estrategias de inmunoterapia

INFORMACIÓN DE CONTACTO
Foto Equipo
Grupo de Investigación

LASARTE SAGASTIBELZA, JUAN JOSE
  Correo Electrónico jjlasarte@unav.es


Foto Grupo

ARDAIZ IRIARTE, NURIA
BELSUE URQUIZU, VIRGINA
Repáraz, D, Casares, N, Fuentes, A, Navarro, F "Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment".
 Methods Cell Biol.. 185: 79 - 97. 2024. [doi:10.1016/bs.mcb.2024.02.006]
Arrizabalaga, L, Di Trani, CA, Risson, A, Belsúe, V, Gomar, C, Ardaiz, N, Berrondo, P, Aranda, F, Bella, A "Peritoneal carcinomatosis in mouse models".
 Methods Cell Biol.. 185: 67 - 78. 2024. [doi:10.1016/bs.mcb.2024.02.005]
Salgado-Pascual, A, Zalba, S, Lasarte, JJ, Garrido, MJ "Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape".
 Adv. Drug Deliv. Rev.. 229: 115760 - 115760. 2026. [doi:10.1016/j.addr.2025.115760]
Arrizabalaga, L, Melero, I, Berraondo, P, Aranda, F "Routing immunomodulatory cytokine-encoded mRNAs to the omentum: turning an enemy into an ally in peritoneal metastasis".
 OncoImmunology. 14(1): 2510998 - 2510998. 2025. [doi:10.1080/2162402X.2025.2510998]
imagen
Llopiz, D, Silva, L, Ruiz, M, Castro-Alejos, C, Aparicio, B, Vegas, L, Infante, S, Santamaria, E, Sarobe, P "MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma".
 OncoImmunology. 14(1): 2473165 - 2473165. 2025. [doi:10.1080/2162402X.2025.2473165]
imagen
Gomar, C, Risson, A, Arrizabalaga, L, Ardaiz, N, Belsue, V, Gil-Korilis, A, Ahmadi-Erber, S, Schippers, T, Melero, I, Orlinger, KK, Aranda, F, Lauterbach, H, Berraondo, P "The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis".
 OncoImmunology. 14(1): 2520266 - 2520266. 2025. [doi:10.1080/2162402X.2025.2520266]
imagen
Pojar, K, Reckendorfer, D, Strauss, J, Szaffich, S, Ahmadi-Erber, S, Schippers, T, Berraondo, P, Orlinger, KK, Raguz, J, Lauterbach, H "Combining local cytokine delivery and systemic immunization with recombinant artLCMV boosts antitumor efficacy in several preclinical tumor models".
 OncoImmunology. 14(1): 2514040 - 2514040. 2025. [doi:10.1080/2162402X.2025.2514040]
imagen
Navarro, F, Lozano, T, Fuentes-Garcia, A, Sánchez-Moreno, I, Larrayoz, M, Justicia, P, Perucha, B, Martinez-Tabar, M, Martinez-Turrillas, R, Casares, N, Martín-Otal, C, Gorraiz, M, Meermeier, EW, Chesi, M, Lake, D, Bergsagel, PL, Santamaría, E, Calleja-Cervantes, ME, San Martín-Uriz, P, Jordana-Urriza, L, Agirre, X, Hervás-Stubbs, S, Rodriguez-Madoz, JR, Martinez-Climent, JA, Prosper, F, Lasarte, JJ "Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma".
 Blood. 146(24): 2931 - 2944. 2025. [doi:10.1182/blood.2024027496]
imagen
Aranda, F, Risson, A, Berraondo, P "Trispecific engager overcomes tumoural immunosuppressive environment Immunotherapy".
 Nat. Biomed. Eng. . 2025. [doi:10.1038/s41551-025-01571-w]
Tavira, A, Basurco, L, Abellanas, MA, Ayerra, L, Vidaurre, C, Luquin, E, Vales, A, Gonzalez-Aseguinolaza, G, Marrodan, L, Alonso, MM, Mengual, E, Tansey, MG, Hervás-Stubbs, S, Aymerich, MS "Inhibition of T cell infiltration and soluble TNF signaling is neuroprotective in the alpha-synuclein overexpressing mouse model of Parkinson's disease".
 npj Parkinsons Dis.. 11(1): 315 - 315. 2025. [doi:10.1038/s41531-025-01158-x]
imagen
Anterior 1 2 3 4 5 6 7 8 9 10  ... Siguiente